269 related articles for article (PubMed ID: 35169832)
21. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
22. Human liver single nucleus and single cell RNA sequencing identify a hepatocellular carcinoma-associated cell-type affecting survival.
Alvarez M; Benhammou JN; Darci-Maher N; French SW; Han SB; Sinsheimer JS; Agopian VG; Pisegna JR; Pajukanta P
Genome Med; 2022 May; 14(1):50. PubMed ID: 35581624
[TBL] [Abstract][Full Text] [Related]
23. Clinical and Prognostic Value of
Mou L; Jia C; Wu Z; Xin B; Liang Zhen CA; Wang B; Ni Y; Pu Z
Cells; 2022 Sep; 11(19):. PubMed ID: 36231045
[TBL] [Abstract][Full Text] [Related]
24. Single-cell transcriptome analysis reveals the metabolic changes and the prognostic value of malignant hepatocyte subpopulations and predict new therapeutic agents for hepatocellular carcinoma.
Han C; Chen J; Huang J; Zhu R; Zeng J; Yu H; He Z
Front Oncol; 2023; 13():1104262. PubMed ID: 36860314
[TBL] [Abstract][Full Text] [Related]
25. Analysis on heterogeneity of hepatocellular carcinoma immune cells and a molecular risk model by integration of scRNA-seq and bulk RNA-seq.
Liu X; Li J; Wang Q; Bai L; Xing J; Hu X; Li S; Li Q
Front Immunol; 2022; 13():1012303. PubMed ID: 36311759
[TBL] [Abstract][Full Text] [Related]
26. Integration of single-cell and bulk RNA-sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model.
Mu Y; Zheng D; Peng Q; Wang X; Zhang Y; Yin Y; Wang E; Ye F; Wang J
Cancer Rep (Hoboken); 2024 Jan; 7(1):e1935. PubMed ID: 37994394
[TBL] [Abstract][Full Text] [Related]
27. Weighted correlation gene network analysis reveals a new stemness index-related survival model for prognostic prediction in hepatocellular carcinoma.
Zhang Q; Wang J; Liu M; Zhu Q; Li Q; Xie C; Han C; Wang Y; Gao M; Liu J
Aging (Albany NY); 2020 Jul; 12(13):13502-13517. PubMed ID: 32644941
[TBL] [Abstract][Full Text] [Related]
28. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma.
Liu T; Wu H; Qi J; Qin C; Zhu Q
Cancer Med; 2020 Oct; 9(20):7440-7452. PubMed ID: 32815653
[TBL] [Abstract][Full Text] [Related]
29. Identification and validation of EPHX2 as a prognostic biomarker in hepatocellular carcinoma.
Zhan K; Bai Y; Liao S; Chen H; Kuang L; Luo Q; Lv L; Qiu L; Mei Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278494
[TBL] [Abstract][Full Text] [Related]
30. Molecular subtypes based on immune-related genes predict the prognosis for hepatocellular carcinoma patients.
Hu B; Yang XB; Sang XT
Int Immunopharmacol; 2021 Jan; 90():107164. PubMed ID: 33172741
[TBL] [Abstract][Full Text] [Related]
31. Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.
Li GX; Ding ZY; Wang YW; Liu TT; Chen WX; Wu JJ; Xu WQ; Zhu P; Zhang BX
J Cell Physiol; 2019 Jul; 234(7):11942-11950. PubMed ID: 30536816
[TBL] [Abstract][Full Text] [Related]
32. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression.
Zhou L; Yu KH; Wong TL; Zhang Z; Chan CH; Loong JH; Che N; Yu HJ; Tan KV; Tong M; Ngan ES; Ho JW; Ma S
Gut; 2022 Aug; 71(8):1656-1668. PubMed ID: 34588223
[TBL] [Abstract][Full Text] [Related]
33. Single-cell RNA sequencing revealed potential targets for immunotherapy studies in hepatocellular carcinoma.
Xie Z; Huang J; Li Y; Zhu Q; Huang X; Chen J; Wei C; Luo S; Yang S; Gao J
Sci Rep; 2023 Nov; 13(1):18799. PubMed ID: 37914817
[TBL] [Abstract][Full Text] [Related]
34. Single-cell transcriptome analysis identifies novel biomarkers involved in major liver cancer subtypes.
Swain AK; Pandey P; Sera R; Yadav P
Funct Integr Genomics; 2023 Jul; 23(3):235. PubMed ID: 37438675
[TBL] [Abstract][Full Text] [Related]
35. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract][Full Text] [Related]
36. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients.
Wang J; Han K; Zhang C; Chen X; Li Y; Zhu L; Luo T
Biosci Rep; 2021 May; 41(5):. PubMed ID: 33988674
[TBL] [Abstract][Full Text] [Related]
38. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
39. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
40. Onco-fetal Reprogramming of Endothelial Cells Drives Immunosuppressive Macrophages in Hepatocellular Carcinoma.
Sharma A; Seow JJW; Dutertre CA; Pai R; Blériot C; Mishra A; Wong RMM; Singh GSN; Sudhagar S; Khalilnezhad S; Erdal S; Teo HM; Khalilnezhad A; Chakarov S; Lim TKH; Fui ACY; Chieh AKW; Chung CP; Bonney GK; Goh BK; Chan JKY; Chow PKH; Ginhoux F; DasGupta R
Cell; 2020 Oct; 183(2):377-394.e21. PubMed ID: 32976798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
